MedPath

Young People Aged 18-25 With Depression or Anxiety Mood Participate in an LLM-based Digital Dialogue Intervention Study

Not Applicable
Completed
Conditions
Anxiety
LLM-based AI Dialogue Bot
Depression
Interventions
Other: Douyin Xinqing AI dialog bot for delayed intervention
Other: Douyin Xinqing AI dialog bot
Registration Number
NCT06346496
Lead Sponsor
Institute of Psychology, Chinese Academy of Sciences
Brief Summary

This study is a 28-day randomized controlled trial (RCT). Residents were randomly assigned to an intervention group or a waiting group according to the order in which they were successfully contacted by the staff, and each user was asked to engage in a total of 28 days of dialog intervention with the Douyin companion bot and complete three psychological questionnaires (on Days 1, 14, and 28); however, the intervention group began to receive the dialog intervention after completing the first questionnaire, and the waiting group began to receive the dialog intervention after completing the third questionnaire. During the first four weeks, the waiting group was treated as a blank control. The two groups of subjects completed the three questionnaires at exactly the same point in time. Each user's depression, anxiety, and positive and negative emotions were measured using the Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder Scale (GAD-7) and the Positive and Negative Affect Schedule (PANAS), respectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
657
Inclusion Criteria
  • 18-25 years old
  • Proficient in Chinese
  • Not dyslexic
  • Scoring at least 5 on the PHQ-9 or GAD-7
  • Not having a serious physical or diagnosed mental illness
Exclusion Criteria
  • Unwilling to continue to participate in the study
  • Insufficient clocking in

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Waiting groupDouyin Xinqing AI dialog bot for delayed interventionThe waiting group received the same intervention as the intervention group after a 28-day waiting period.
AI conversation interventionDouyin Xinqing AI dialog botParticipants in the intervention group received a 28-day AI conversation intervention after completing the baseline questionnaire. We asked users in the intervention group to use the web link every day, upload the start and end times of their conversations with the AI bot and screenshots of their chats; users who chatted for more than 5 minutes were considered to have successfully punched in for that day. Participants who clocked more than 8 days in the first 14 days were allowed to complete the second questionnaire at the two-week mark. Similarly, participants who quit more than eight times between days 15 and 28 could complete the third questionnaire at the four-week mark. Therefore, all users in the intervention group who completed the third questionnaire received at least 16 AI conversation interventions.
Primary Outcome Measures
NameTimeMethod
DepressionThe day before the start of the intervention, day 14 and day 28 after the start of the intervention

Depression was assessed with the Patient Health Questionnaire (PHQ-9). The PHQ-9 contains nine items scored on a scale from 0 (not at all) to 3 (almost every day) based on the self-reported frequency of depressive symptoms in the past 2 weeks. The total score ranges from 0 to 27, and scores above 10 indicate probable depression symptoms.

AnxietyThe day before the start of the intervention, day 14 and day 28 after the start of the intervention

Anxiety was assessed with the Chinese version of the Generalized Anxiety Disorder Scale (GAD-7). The 7 items are rated on a 4-point scale ranging from 0 (never) to 3 (almost every day) to assess the frequency of anxiety symptoms in the past 2 weeks. The total score ranges from 0 to 21, and according to the established criteria, scores above 10 indicate probable anxiety symptoms.

Positive and negative moodsThe day before the start of the intervention, day 14 and day 28 after the start of the intervention

Positive and negative moods were assessed with the Positive and Negative Affect Schedule (PANAS). The scale was categorized into two dimensions, positive (PA) and negative (NA), and each dimension was scored independently, with 9 items per dimension. All the items are rated on a 5-point scale ranging from 1 (few) to 5 (very much). The higher the subject's score on a subscale is, the stronger the associated emotion experienced.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institute of Psychology, Chinese Academy of Sciences

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath